Zhu et al. were the first to report that there is an increase in both Sox9 mRNA and protein levels in human osteosarcoma, and that this upregulation is associated with the advancement of the tumor and poor prognosis in patients [29]. This evidence concerns the gene SOX9 and neoplasm.